Speeches by Hoare.

“Is it your assessment, on the basis of where there’s a will there’s a way, that if there is a need for a product, whatever the product might be, it would be available should need be there, as long as the certificate requirements are met?”

“Is it your assessment that there is an appetite for and preparedness to work towards a regime between producer and end user—the vet—in order to minimise disruption to supply, notwithstanding the fact that there may be some degree of onerousness with regard to applying for the certificate?”

“Would responsibility for that certificate rest with the veterinary surgeon to secure or with the producer in the pharmaceutical sector?”

“Yes, indeed. Is it your assessment that there is no other legitimate route—I underscore the word “legitimate”—to secure access to these treatments?”

“Where are we on access to the usual medicines that a vet will prescribe to a pet owner on a daily basis, in terms of percentages and figures?”

“Are you able to give us some indication of percentage? What is your level of concern about certain medicines and treatments from the pharmaceutical sector that will not be or would not be available?”

“Good morning, Dr Dunbar. Business obviously wants to sell its product, and many have demonstrated in recent times considerable agility in meeting the new tests and challenges. Could you talk us through your understanding of the adjustments which have already been made by the pharmaceutical industry itself, to ensure co…”

“Before I bring in Dr Whitten, there seems to be a theme emerging that the domestic processes of evaluation, assessment and response written for a different period of time are potentially not fit for purpose to meet the in-real-time, analysis-response legislating that we may find ourselves facing. Is that a fair assessm…”

“I want to draw out all three of you on this point, which may help this Committee when it makes recommendations to Government in its report following this inquiry. For too many people, Brexit was seen as an event rather than a process to be implemented over time, with different events that would occur and would need to …”

“I was not asking you, Mr Robinson.”

“I am still trying to find my yes or no answer.”

“You win the prize for shortest answer, which is usually the most well received.”

“Is that a yes or a no?”

“Thank you.”

“Good morning, Dr Dunbar. Business obviously wants to sell its product, and many have demonstrated in recent times considerable agility in meeting the new tests and challenges. Could you talk us through your understanding of the adjustments which have already been made by the pharmaceutical industry itself, to ensure co…”

“Are you able to give us some indication of percentage? What is your level of concern about certain medicines and treatments from the pharmaceutical sector that will not be or would not be available?”

“Where are we on access to the usual medicines that a vet will prescribe to a pet owner on a daily basis, in terms of percentages and figures?”

“Would responsibility for that certificate rest with the veterinary surgeon to secure or with the producer in the pharmaceutical sector?”

“I echo the Minister in thanking Rebecca Hilsenrath for the work she has done in stepping into an interim role and fulfilling that job with great distinction. I also thank the Prime Minister and the wider Cabinet Office for the speed with which they responded to the recommendation from the interview panel, which I had t…”

“Taking on board the minimum time requirements of your other roles, we are all very conscious of the scale of the task at hand, as you said in your answers. Notwithstanding your other non-S4C commitments, are you able to undertake that you would take on no further non-S4C time obligations?”